Associated Medical Conditions for Alzheimer's disease

The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Percent Est Matches Bacteria in From Bacteria in To
Allergies 12 % 6 50 50
Ankylosing spondylitis 46 % 23 520 50
Autism 40 % 20 110 50
Ulcerative colitis 38 % 19 108 50
Rosacea 27.3 % 6 22 50
Multiple Sclerosis 46 % 23 100 50
Schizophrenia 30 % 15 93 50
Mood Disorders 50 % 3 6 50
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 42 % 21 134 50
Psoriasis 30.4 % 14 46 50
Obesity 22 % 11 55 50
Obesity 30 % 15 104 50
Amyotrophic lateral sclerosis (ALS) Motor Neuron 14 % 6 43 50
Osteoporosis 18.2 % 4 22 50
neuropsychiatric disorders (PANDAS, PANS) 40 % 6 15 50
ME/CFS with IBS 21.1 % 4 19 50
Multiple system atrophy (MSA) 19 % 4 21 50
Metabolic Syndrome 14.3 % 1 7 50
Systemic Lupus Erythematosus 28 % 14 66 50
Liver Cirrhosis 58 % 29 678 50
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 30 % 15 76 50
Parkinson's Disease 36 % 18 90 50
Chronic Kidney Disease 37.1 % 13 35 50
Insomnia 80 % 8 10 50
Depression 30 % 15 81 50
Irritable Bowel Syndrome 24 % 12 62 50
Chronic Urticaria (Hives) 17.4 % 4 23 50
IgA nephropathy (IgAN) 10.3 % 3 29 50
Hyperlipidemia (High Blood Fats) 24 % 6 25 50
hypertension (High Blood Pressure 50 % 3 6 50
hypercholesterolemia (High Cholesterol) 11.1 % 1 9 50
Allergic Rhinitis (Hay Fever) 11.1 % 4 36 50
gallstone disease (gsd) 33.3 % 5 15 50
Graves' disease 12.5 % 1 8 50
Fibromyalgia 21.6 % 8 37 50
Functional constipation / chronic idiopathic constipation 31.7 % 13 41 50
Type 1 Diabetes 32 % 16 52 50
Gout 19 % 4 21 50
Epilepsy 16 % 4 25 50
Cerebral Palsy 41.2 % 7 17 50
Inflammatory Bowel Disease 32 % 16 66 50
Celiac Disease 18 % 9 67 50
cystic fibrosis 14.3 % 1 7 50
COVID-19 13.9 % 5 36 50
Carcinoma 22 % 11 51 50
Bipolar Disorder 36.4 % 12 33 50
Colorectal Cancer 26 % 13 296 50
Chronic Fatigue Syndrome 14 % 7 55 50
Coronary artery disease 18.8 % 3 16 50
Crohn's Disease 48 % 24 141 50
Barrett esophagus cancer 12.5 % 2 16 50
Asthma 22.2 % 6 27 50
Atherosclerosis 32 % 16 524 50
Acne 31.6 % 6 19 50
Stress / posttraumatic stress disorder 28 % 14 56 50
Small Intestinal Bacterial Overgrowth (SIBO) 12.5 % 2 16 50
Brain Trauma 27.3 % 6 22 50
Sjögren syndrome 22 % 9 41 50
Type 2 Diabetes 72 % 36 267 50
ADHD 25.5 % 12 47 50
Hashimoto's thyroiditis 28.6 % 4 14 50

(Legacy User)

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2021 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA